8-K filing — Celularity Inc (CELU)
Filed: 2026-10-29 AccNo: 0001493152-26-049203 Size: 236 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Celularity Enters Manufacturing Agreement With Vesalius For Its Peptual-Branded Peptide Active Pharmaceutical Ingredients
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Celularity Regains Compliance with Nasdaq Periodic Financial Reporting Requirement
Celularity Inc. announced it has received confirmation from Nasdaq that it has regained compliance with the exchange's periodic financial reporting requirements following the filing of its second-quarter 2026 Form 10-Q.
Stock Market: Will S&P 500 Open Up or Down Today?
S&P 500 to open higher? Polymarket odds reach 70% as Wall Street digests September jobs, 24-year high Treasury yields, and Iran sanctions.